Placebo for AZD4144, AZD4144
D9440C00004
Phase 2 small_molecule active
Quick answer
Placebo for AZD4144, AZD4144 for Sepsis-associated acute kidney injury (AKI) is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Sepsis-associated acute kidney injury (AKI)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active